Exposure to the parkinsonian neurotoxin 1-methyl-4-phenylpyridinium (MPP+) and nitric oxide simultaneously causes cyclosporin A-sensitive mitochondrial calcium efflux and depolarisation

Biochemical Pharmacology

Volumn 51, Issue 3, 1996, Pages 267-273

  Packer, Michael A ^a   Miesel, Ralf ^a   Murphy, Michael P ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

1 methyl 4 phenylpyridinium (MPP+); cyclosporin A; mitochondrial calcium transport; nitric oxide; peroxynitrite; rotenone

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; CYCLOSPORIN A; N ACETYL S NITROSOPENICILLAMINE; NEUROTOXIN; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SPERMINE; PEROXYNITRITE; ROTENONE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CHEMOLUMINESCENCE; CONTROLLED STUDY; FEMALE; LIVER MITOCHONDRION; MEMBRANE DEPOLARIZATION; MITOCHONDRIAL MEMBRANE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

EID: 0030020118     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(95)02165-5     Document Type: Article

References (49)

1. Gerlach M, Riederer P, Przuntek H and Youdim MBH, MPTP mechanisms of neurotoxicity and their implication for Parkinson's disease. Eur J Pharmacol 208: 273-286, 1991.
2. Tipton KF and Singer TP, Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. J Neurochem 61: 1191-1206, 1993.
3. Snyder SH and D'Amato RJ, MPTP: A neurotoxin relevant to the pathophysiology of Parkinson's disease. Neurology 36: 250-258, 1986.
4. +) induces NADH dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine submitochondrial particles. Biochem Biophys Res Commun 170: 1049-1055, 1990.
5. Cleeter MJW, Cooper JM and Schapira AHV, Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: Evidence for free radical involvement. J Neurochem 58: 786-789, 1992.
6. +. Biochem Biophys Res Commun 189: 47-52, 1992.
7. Rossetti ZL, Sotgiu A, Sharp DE, Hadjiconstantinou M and Neff NH, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and free radicals in vitro. Biochem Pharmacol 37: 4573-4574, 1988.
8. Przedborski S, Kostic V, Jackson-Lewis V, Naini AB, Simonetti S, Fahn S, Carlson E, Epstein CJ and Cadet JL, Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistent to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. J Neurosci 12: 1658-1667, 1992.
9. + induced oxygen radical formation with mitochondrial enzymes. Free Rad Biol Med 15: 181-186, 1993.
10. Olanow CW, A radical hypothesis for neurodegeneration. TINS 16: 439-444, 1993.
11. Zang LY and Misra HP, Generation of reactive oxygen species during the monoamine oxidase-catalyzed oxidation of the neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. J Biol Chem 268: 16504-12, 1993.
12. Beckman JS, Beckman TW, Chen J, Marshall PA and Freeman BA, Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87: 1620-1624, 1990.
13. Halliwell B and Gutteridge JMC, Free Radicals in Biology and Medicine, second edition. Oxford University Press, New York, 1991.
14. -. Implications for the action of endothelium-derived relaxing factor (EDRF). Free Rad Res Comms 10: 221-226, 1990.
15. Radi R, Beckman JS, Bush KM and Freeman BA, Peroxynitrite oxidation of sulfhydryls. J Biol Chem 266: 4244-4250, 1991.
16. Ischiropoulos H, Zhu L, Chen J, Tsai M, Martin JC, Smith CD and Beckman JS, Peroxynitrite-mediated tyrosine nitration catalysed by superoxide dismutase. Arch Biochem Biophys 298: 431-437, 1992.
17. King PA, Anderson VE, Edwards JO, Gustafson G, Plumb RC and Suggs JA, A stable solid that generates hydroxyl radical upon dissociation in aqueous solutions: reaction with proteins and nucleic acid. J Am Chem Soc 114: 5430-5432, 1992.
18. Moreno J and Pryor W, Inactivation of α1-proteinase inhibitor by peroxynitrite. Chem Res Toxicol 5: 425-431, 1992.
19. Gatti RM, Radi R and Augusto O, Peroxynitrite-mediated oxidation of albumin to the protein-thiyl free radical. FEBS Lett 348: 287-290, 1994.
20. Beckman JS, Ischaemic injury mediator. Nature 345: 27-28, 1990.
21. Matheis G, Sherman MP, Buckberg GD, Haybron DM, Young HH and Ignarro LJ, Role of L-arginine-nitric oxide pathway in myocardial injury. Am J Physiol 262: H616-H620, 1992.
22. Mulligan MS, Hevel JM, Marietta MA and Ward PA, Tissue injury caused by deposition of immune comlexes is L-arginine dependent. Proc Natl Acad Sci USA 88: 6338-6342, 1991.
23. Cazevielle C, Muller A, Meynier F and Bonne C, Superoxide and nitric oxide cooperation in hypoxia/reoxygenation-induced neuron injury. Free Rad Biol Med 14: 389-395, 1993.
24. Darley-Usmar VM, Hogg N, O'Leary V, Wilson MT and Moncada S, The simultaneous generation of superoxide and nitric oxide can initiate lipid peroxidation in human low density lipoprotein. Free Rad Res Comms 17: 9-20, 1992.
25. Beckman JS, Ye YZ, Anderson PG, Chen J, Accavitti MA, Tarpey MM and White CR, Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe-Seyler 375: 81-88, 1994.
26. Beckman JS, Carson M, Smith CD and Koppenol WH, ALS SOD and peroxynitrite. Nature 364: 584, 1993.
27. Lowenstein CJ and Snyder SH, Nitric oxide, a novel biological messenger. Cell 70: 705-707, 1992.
28. Bredt DS and Snyder SH, Nitric oxide: A physiologic messenger molecule. Annu Rev Biochem 63: 175-195, 1994.
29. Malinski T, Bailey F, Zhang ZG and Chopp M, Nitric oxide measured by a porphjyrinic microsensor in rat brain after transient middle cerebral artery occlusion. J Cereb Blood Flow Metab 13: 355-358, 1993.
30. +-induced hydroxyl radical formation and nigrostriatial MPTP toxicity by inhibiting nitric oxide synthase. Neuroreport 5: 2598-2600, 1994.
31. Broekemeier KM, Dempsey ME and Pfeiffer DR, Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria. J Biol Chem 264: 7826-7830, 1989.
32. Nicotera P, Bellomo G and Orrenius S, Calcium-mediated mechanisms in chemically induced cell death. Annu Rev Pharmacol Toxicol 32: 449-470, 1992.
33. Richter C, Mitochondrial calcium transport. In: Molecular Mechanisms in Bioenergetics (Ed. Ernster L), pp. 349-358. Elsevier, Amsterdam, 1992.
34. Crompton M and Andreeva L, On the involvement of a mitochondrial pore in reperfusion injury. Basic Res Cardiol 88: 513-523, 1993.
35. Gunter TE, Gunter KK, Sheu SS and Gavin CE, Mitochondrial calcium transport: Physiolgy and pathological relevance. Am J Physiol 267: C313-C339, 1994.
36. Packer MA and Murphy MP, Peroxynitrite causes calcium efflux from mitochondria which is prevented by Cyclosporin A. FEBS Lett 345: 237-240, 1994.
37. Packer MA and Murphy MP, Peroxynitrite formed by simultaneous nitric oxide and superoxide generation causes Cyclosporin A-sensitive mitochondrial calcium efflux and depolarisation. Eur J Biochem, in press.
38. Diodati JG, Quyyumi AA and Keefer LK, Complexes of nitric oxide with neucleophiles as agents for the controlled biological release of nitric oxide: Hemodynamic effects in the rabbit. J Cardiovasc Pharmacol 22: 287-292, 1993.
39. Chappell JB and Hansford RG, Preparation of mitochondria from animal tissues and yeasts. In: Subcellular Components: Preparation and Fractionation, 2nd edition (Ed. Birnie GD), pp. 77-91, Butterworths, London, 1972.
40. Gornall AG, Bardawill CJ and David MM, Determination of serum proteins by means of the biuret rection. J Biol Chem 177: 751-766, 1949.
41. Reichman N, Porteous CM and Murphy MP, Cyclosporin A blocks 6-hydroxydopamine-induced efflux of calcium from mitochondria without inactivating the mitochondrial inner membrane pore. Biochem J 297: 151-155, 1994.
42. Smith AL, Preparation, properties, and conditions for assay of mitochondria: Slaughterhouse material, small scale. Methods Enzymol 10: 81-86, 1967.
43. Ackerman KEO and Wikstrom MKF, Safranine as a probe of the mitochondrial membrane potential. FEBS Lett 68: 191-197, 1976.
44. Kooy NW, Royall JA, Ischiropoulos H and Beckman JS, Peroxynitrite-mediated oxidation of dihydrorhodamine 123. Free Rad Biol Med 16: 149-156, 1994.
45. Gylenhammar H, Lucigenin chemiluminescence in the assessment of neutrophil superoxide production. J Immunol Methods 97: 209-213, 1987.
46. Turrens JF and Boveris A, Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem J 191: 421-427, 1980.
47. 2+ release from mitochondria induced by prooxidants. Free Radical Biology & Medicine 4: 365-375, 1988.
48. 2+ binding sites with opposing effects on the pore open probability. J Biol Chem 268: 1005-10, 1993.
49. +: Implications for neurodegeneration. J Neurochem 63:584-591, 1994.